DOE Recognizes Synthetic Biology Pioneer Jay Keasling with 2025 OTC/NAI Innovator of the Year Award

CEND affiliate Jay Keasling, a UC Berkeley professor and synthetic biology pioneer, has been named the 2025 OTC/NAI Innovator of the Year by the U.S. Department of Energy. Renowned for engineering microbes to produce affordable artemisinin, the critical antimalarial drug, and advancing biofuels, chemicals, and pharmaceuticals through metabolic engineering, his innovations are transforming global health and sustainable energy. Find more about the full recognition here.